Responses of

Consumption of diets high in hydrogenated fat/trans fatty acids has been shown to have an adverse affect on lipoprotein profiles with respect to cardiovascular disease risk. Dietary fat and cholesterol play an important role in the regulation of immune and inflammatory responses shown to be involved in atherogenesis. We investigated the effects of diets containing hydrogenated fat on cellular immune response and production of inflammatory cytokines in human subjects with moderately elevated cholesterol levels (LDL cholesterol >130 mg/dl). In a double blind cross-over study, 19 subjects consumed three diets, 30% of calories as fat, of which two thirds were provided as soybean oil, soybean oil-based stick margarine, or butter for 32 days, each in a randomized order. Production of proinflammatory mediators, prostaglandin (PG)E(2), interleukin (IL)-1beta, IL-6, and tumor necrosis factor alpha (TNF-alpha); delayed type hypersensitivity (DTH) response, in vitro lymphocyte proliferation, and production of IL-2 were determined. Production of IL-6 and TNF-alpha was significantly higher after consumption of stick margarine diet compared with soybean oil diet. IL-1beta and TNF-alpha production correlated positively with ratios of total cholesterol to HDL cholesterol (r = 0.499, P < 0.001 and r = 0.291, P = 0.04, respectively). There was no significant difference in DTH response, lymphocyte proliferation, or levels of IL-2 and PGE(2) produced among three groups. Our results indicate that consumption of a diet high in hydrogenated fat does not adversely affect cellular immunity but increases production of inflammatory cytokines that have been associated with the pathophysiology of atherosclerosis.

[1]  D. Kaul Molecular link between cholesterol, cytokines and atherosclerosis , 2001, Molecular and Cellular Biochemistry.

[2]  H. Arnesen,et al.  Reduced levels of TNF alpha in hypercholesterolemic individuals after treatment with pravastatin for 8 weeks. , 2001, Atherosclerosis.

[3]  S. Rhee,et al.  Saturated Fatty Acids, but Not Unsaturated Fatty Acids, Induce the Expression of Cyclooxygenase-2 Mediated through Toll-like Receptor 4* , 2001, The Journal of Biological Chemistry.

[4]  R. Zinkernagel,et al.  Hypercholesterolemia Exacerbates Virus-Induced Immunopathologic Liver Disease Via Suppression of Antiviral Cytotoxic T Cell Responses1 , 2001, The Journal of Immunology.

[5]  R. Klein,et al.  Effect of inflammatory cytokines on the metabolism of low-density lipoproteins by human vascular endothelial cells. , 2001, Metabolism: clinical and experimental.

[6]  E. Ikonen,et al.  How cells handle cholesterol. , 2000, Science.

[7]  F. Parhami,et al.  Tumor Necrosis Factor-&agr; Promotes In Vitro Calcification of Vascular Cells via the cAMP Pathway , 2000, Circulation.

[8]  J. Nilsson,et al.  Accumulation of LDL in Rat Arteries Is Associated With Activation of Tumor Necrosis Factor-&agr; Expression , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[9]  A. Lichtenstein,et al.  Hydrogenated fat consumption affects cholesterol synthesis in moderately hypercholesterolemic women. , 2000, Journal of lipid research.

[10]  P. Ridker,et al.  Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. , 2000, Circulation.

[11]  A. Weverling-Rijnsburger,et al.  Hyperlipoproteinemia affects cytokine production in whole blood samples ex vivo. The influence of lipid-lowering therapy. , 2000, Atherosclerosis.

[12]  S. Humphries,et al.  Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? , 2000, Atherosclerosis.

[13]  D. Hwang,et al.  Fatty acids and immune responses--a new perspective in searching for clues to mechanism. , 2000, Annual review of nutrition.

[14]  S. Rhee,et al.  Receptor-mediated signaling pathways: potential targets of modulation by dietary fatty acids. , 1999, The American journal of clinical nutrition.

[15]  P. Sakkinen,et al.  Interleukin-6 exacerbates early atherosclerosis in mice. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[16]  A. Lichtenstein,et al.  Effects of different forms of dietary hydrogenated fats on serum lipoprotein cholesterol levels. , 1999, The New England journal of medicine.

[17]  K. Williams,et al.  Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.

[18]  J. Rutledge,et al.  17β-Estradiol reduces tumor necrosis factor-α-mediated LDL accumulation in the artery wall , 1999 .

[19]  F. Kummerow,et al.  Hydrogenated fat high in trans monoenes with an adequate level of linoleic acid has no effect on prostaglandin synthesis in rats. , 1999, The Journal of nutrition.

[20]  P. Libby,et al.  Reduction of atherosclerosis in mice by inhibition of CD40 signalling , 1998, Nature.

[21]  P. Calder,et al.  Fat chance of immunomodulation. , 1998, Immunology today.

[22]  A. Hamsten,et al.  Evidence for a role of tumor necrosis factor alpha in disturbances of triglyceride and glucose metabolism predisposing to coronary heart disease. , 1998, Metabolism: clinical and experimental.

[23]  Y. Yazaki,et al.  Inflammatory cytokines cause coronary arteriosclerosis-like changes and alterations in the smooth-muscle phenotypes in pigs. , 1997, Journal of cardiovascular pharmacology.

[24]  P. Mills,et al.  Modified low density lipoprotein and cytokines mediate monocyte adhesion to smooth muscle cells. , 1996, Atherosclerosis.

[25]  J. Nilsson,et al.  Human Monocytes/Macrophages Release TNF-α in Response to Ox-LDL , 1996 .

[26]  E. Chan,et al.  TNF-α-induced Regulation and Signalling in Macrophages , 1996 .

[27]  C. Holt,et al.  Interleukin-1β in Coronary Arteries of Patients With Ischemic Heart Disease , 1996 .

[28]  M. Cybulsky,et al.  Immunology of atherosclerosis: the promise of mouse models. , 1996, The American journal of pathology.

[29]  G. Hansson,et al.  Evidence for a local immune response in atherosclerosis. CD4+ T cells infiltrate lesions of apolipoprotein-E-deficient mice. , 1996, The American journal of pathology.

[30]  M. Eldar,et al.  Increased serum concentrations of interleukin-1 beta in patients with coronary artery disease. , 1996, Heart.

[31]  P. Libby,et al.  Regulation of smooth muscle cell scavenger receptor expression in vivo by atherogenic diets and in vitro by cytokines. , 1995, The Journal of clinical investigation.

[32]  K. Feingold,et al.  Effects of TNF, IL-1, and the combination of both cytokines on cholesterol metabolism in Syrian hamsters. , 1994, Lymphokine and cytokine research.

[33]  J. Ordovás,et al.  Rice bran oil consumption and plasma lipid levels in moderately hypercholesterolemic humans. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[34]  H. Rasmussen,et al.  Immunologic effects of national cholesterol education panel step-2 diets with and without fish-derived N-3 fatty acid enrichment. , 1993, The Journal of clinical investigation.

[35]  J. Manson,et al.  Intake of trans fatty acids and risk of coronary heart disease among women , 1993, The Lancet.

[36]  P. Taylor,et al.  Concentration of dietary N-6 polyunsaturated fatty acids and the human immune status. , 1992, Clinical immunology and immunopathology.

[37]  Qingbo Xu,et al.  Correlation of lymphocyte lipid composition membrane microviscosity and mitogen response in the aged , 1991, European journal of immunology.

[38]  B. Goldin,et al.  Effect of oral n-3 fatty acid supplementation on the immune response of young and older women. , 1991, Advances in prostaglandin, thromboxane, and leukotriene research.

[39]  J. Van Snick Interleukin-6: an overview. , 1990, Annual review of immunology.

[40]  H. Gerlach,et al.  Tumor necrosis factor/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G proteins , 1989, The Journal of experimental medicine.

[41]  E. Schaefer,et al.  Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions. , 1987, Clinica chimica acta; international journal of clinical chemistry.

[42]  J. Albers,et al.  Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. , 1982, Clinical chemistry.

[43]  R. Loria,et al.  Inhibition of host resistance by nutritional hypercholesteremia , 1979, Infection and immunity.

[44]  Kendall A. Smith,et al.  T cell growth factor: parameters of production and a quantitative microassay for activity. , 1978, Journal of immunology.

[45]  J. Dupont,et al.  Radioimmunoassay of prostaglandins E1, E2, and F2alpha in unextracted plasma, serum and myocardium. , 1976, Prostaglandins.

[46]  R. Loria,et al.  Infection of hypercholesterolemic mice with Coxsackievirus B. , 1976, The Journal of infectious diseases.

[47]  R. Havel,et al.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. , 1955, The Journal of clinical investigation.